On August 27, 2025 BridgeBio Pharma, Inc. (Nasdaq: BBIO) ("BridgeBio" or the "Company"), a new type of biopharmaceutical company focused on genetic diseases, reported that members of its management team will host fireside chats at the following healthcare investor conferences (Press release, BridgeBio, AUG 27, 2025, View Source [SID1234655526]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Wells Fargo Healthcare Conference, Boston, MA: Fireside chat on Wednesday, September 3 at 9:30 am ET
Cantor Global Healthcare Conference – New York, NY: Fireside chat on Thursday, September 4 at 2:10 pm ET
Morgan Stanley Global Healthcare Conference – New York, NY: Fireside chat on Monday, September 8 at 3:20 pm ET

To access the live webcast of BridgeBio’s presentations, please visit the "Events and Presentations" page within the Investors section of the BridgeBio website at View Source A replay of the webcasts will be available on the BridgeBio website for 90 days following the event.